Cuba Has an Experimental Alzheimer’s Drug In Human Trials
Cuba has quietly been developing their own Alzheimer’s treatment. It’s administered nasally. And it’s just entered clinical trials. The United States imposed a blockade…
Cuba has quietly been developing their own Alzheimer’s treatment. It’s administered nasally. And it’s just entered clinical trials. The United States imposed a blockade…
While there is a lack of evidence supporting the use of natural supplements for Alzheimer’s disease, experts share best practices for those who are still…
Researchers in Tokyo continue encouraging research on oxytocin as a potential Alzheimer’s drug target. When administered nasally, the hormone appeared to reverse cognitive decline…
Canine cognitive dysfunction looks a lot like Alzheimer’s and dementia in humans. Could a disease-modifying intervention that seems effective our furry companions also work for…
Bombshell exposé in Science magazine and follow-up reporting “make a mountain out of a molehill,” leading Alzheimer’s experts say. The media is reporting that…
Better Alzheimer’s treatments are going to require better models of Alzheimer’s brains in the lab, researchers say. Psychology researcher Étienne Aumont at the University…
Biogen and Eisai’s next disease-modifying Alzheimer’s drug candidate, lecanemab, has been granted FDA priority review, signaling that a decision could be made by early…